About DaBomb Protein
DaBomb Protein is a company based in Tainan (Taiwan) founded in 2001. The company has 46 employees as of December 31, 2024. DaBomb Protein operates in a competitive market with competitors including Pharmaron, Pfizer, Boehringer Ingelheim, Lonza and Dotmatics, among others.
- Headquarter Tainan, Taiwan
- Employees 46 as on 31 Dec, 2024
- Stage Public
-
Sectors
AgricultureHealthcare Consumer
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Dabomb Protein Biotech Corporation
-
Annual Revenue
$337.82 M-12.12as on Dec 31, 2024
-
Net Profit
$11.64 M120.41as on Dec 31, 2024
-
EBITDA
$11.88 M244.7as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
46
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of DaBomb Protein
DaBomb Protein is a publicly listed company on the TPEX with ticker symbol 6578 in Taiwan, operating in the Consumer non-durables sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of DaBomb Protein
Detailed funding history for DaBomb Protein
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DaBomb Protein
Investment portfolio details for DaBomb Protein
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DaBomb Protein
Detailed financials for DaBomb Protein
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dabomb Protein Comparisons
Peer comparison for DaBomb Protein
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DaBomb Protein
DaBomb Protein operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Pfizer, Boehringer Ingelheim, Lonza and Dotmatics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug discovery and development services for small molecules are provided.
|
|
| Locked | Locked | Locked |
Pharmaceutical products for treating multiple diseases are provided.
|
|
| Locked | Locked | Locked |
Generic drugs and clinical research services are provided globally.
|
|
| Locked | Locked | Locked |
CDMO services for pharma, biotech, and specialty ingredients are provided.
|
|
| Locked | Locked | Locked |
AI powered scientific data management and workflow automation solutions
|
|
| Locked | Locked | Locked |
Laboratory testing, clinical trial research, and biopharma services are provided.
|
Detailed competitors of DaBomb Protein
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dabomb Protein
Complete news archive for DaBomb Protein
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DaBomb Protein
DaBomb Protein was founded in 2001.
DaBomb Protein is headquartered in Tainan, Taiwan.
As of Dec 31, 2024, the latest employee count at DaBomb Protein is 46.
DaBomb Protein, established in 2001 and currently in Public stage, focuses on producing consumer products, pet care products, food supplements, health supplements, and multi category. Manufacturer of protein food for pets. Adapting to market demands with innovation and client-focused strategies.
Yes, DaBomb Protein is publicly traded on TPEX under the ticker symbol 6578.
The ticker symbol of DaBomb Protein is 6578 on TPEX.